A complete application in a minute — tailored resume and cover letter, ready to send.
Indiana University Health's Department of Obstetrics & Gynecology invites a Board-Certified Gynecologic Oncologist to join its academic division, serving as primary referral center for complex gynecologic cancer care in Indiana.
This exceptional opportunity emphasizes teaching medical students and OB/GYN residents, collaboration across cancer care teams, and opportunities for research, scholarly activities, and future fellowship development at IU's only NCI-designated Comprehensive Cancer Center.
The Department of Obstetrics & Gynecology at Indiana University Health and the Indiana University School of Medicine (IUSM) is seeking a Board-Certified Gynecologic Oncologist to join its established and growing Academic Gynecologic Oncology Division. This position is part of a highly collaborative, mission-driven program that serves as the primary referral center for complex gynecologic cancer care across the state of Indiana.
This is an exceptional opportunity to practice in a collegial academic environment at Indiana’s only NCI-designated Comprehensive Cancer Center, supported by strong clinical volumes, robust multidisciplinary infrastructure, and meaningful opportunities for teaching and scholarly work.
, the largest medical school in the US, is a national leader in medical research and education. With more than 60 academic departments and specialty divisions across nine campuses statewide and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, the school is continuously advancing its mission to prepare healers and transform health in Indiana and throughout the world.
Campus locations include Bloomington, Evansville, Ft. Wayne, Gary, Indianapolis, Lafayette, Muncie, South Bend, Terre Haute.
With nearly 2000 full-time faculty and the support of more than 3000 volunteer faculty throughout Indiana—all teaching the physicians of tomorrow, IU School of Medicine is uniquely equipped to prepare the next generation of healers and transform health and wellness throughout the United States and beyond.
We are an equal opportunity employer and value diversity and inclusion at IU Health. IU Health does not discriminate on the basis of race, color, religion, sex, sexual orientation, age, disability, genetic information, veteran status, national origin, gender identity and/or expression, marital status or any other characteristic protected by federal, state, or local law. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Healthcare providers at IU Health Melvin and Bren Simon Cancer Center not only offer the highest level of patient care but many are engaged in research. As the only National Cancer Institute (NCI)-designated cancer center in the state of Indiana, IU Health Simon Cancer Center’s researchers are recognized for meeting rigorous criteria for world-class, state-of-the-art programs in multidisciplinary cancer research. NCI-designated cancer centers put significant resources into developing research programs, faculty and facilities that will lead to better approaches to prevention, diagnosis and treatment of cancer.
In 2022, the IU Health Melvin and Bren Simon Cancer Center was admitted as a member of the National Comprehensive Cancer Network, an alliance of 32 leading cancer centers devoted to patient care, research and education.
The mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with patient-centered care, acceleration of promising science and collaborative educational programs. Research is vigorous, innovative and devoted to taking improved cancer care into the future. In all, more than 200 physicians, nurses, social workers, techologists and researchers are working to develop cures for cancer.
That teamwork leads to clinical breakthroughs, such as turning the cure rate of testicular cancer from 10 percent to nearly 95 percent today, among many others. The benefits to patients are clear: a wide range of innovative treatment options, expert teams of diverse professionals focused on their specific cancer type, and attention to all cancer care needs in one setting.